Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,187 | 1,022 | 99.7% |
| Education | $39.49 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,856 | 149 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,826 | 95 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,094 | 82 | $0 (2023) |
| Lilly USA, LLC | $1,075 | 51 | $0 (2024) |
| PFIZER INC. | $885.84 | 147 | $0 (2024) |
| ABBVIE INC. | $854.51 | 63 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $824.54 | 34 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $815.23 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $503.20 | 33 | $0 (2024) |
| Daiichi Sankyo Inc. | $460.66 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,183 | 51 | AstraZeneca Pharmaceuticals LP ($448.82) |
| 2023 | $1,656 | 80 | Bayer Healthcare Pharmaceuticals Inc. ($208.34) |
| 2022 | $2,758 | 163 | Bayer HealthCare Pharmaceuticals Inc. ($360.91) |
| 2021 | $2,610 | 168 | AstraZeneca Pharmaceuticals LP ($256.52) |
| 2020 | $1,622 | 131 | Novo Nordisk Inc ($340.50) |
| 2019 | $1,638 | 158 | Novo Nordisk Inc ($376.73) |
| 2018 | $1,549 | 143 | Novo Nordisk Inc ($308.10) |
| 2017 | $2,210 | 133 | Lilly USA, LLC ($451.10) |
All Payment Transactions
1,027 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $126.63 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $104.91 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Obesity | ||||||
| 07/29/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 07/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 07/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: VACCINES | ||||||
| 07/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 986 | 1,099 | $149,782 | $74,258 |
| 2022 | 21 | 1,052 | 1,267 | $147,617 | $107,470 |
| 2021 | 21 | 927 | 1,128 | $123,737 | $87,573 |
| 2020 | 24 | 937 | 1,119 | $109,966 | $64,093 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 231 | 283 | $52,393 | $28,217 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 217 | $26,797 | $14,993 | 55.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 84 | 84 | $16,825 | $11,770 | 70.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 103 | 104 | $12,780 | $8,645 | 67.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,748 | $3,629 | 37.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $5,996 | $3,598 | 60.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 31 | $4,960 | $510.26 | 10.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 16 | 16 | $480.00 | $431.20 | 89.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 48 | 50 | $1,650 | $420.00 | 25.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 40 | $1,240 | $400.84 | 32.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 27 | $3,942 | $354.24 | 9.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 33 | 34 | $4,284 | $351.90 | 8.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 34 | 35 | $2,170 | $266.35 | 12.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 24 | 24 | $2,040 | $228.48 | 11.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,650 | $227.80 | 13.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 11 | 11 | $1,265 | $97.24 | 7.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 29 | $662.00 | $63.80 | 9.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 11 | 11 | $440.00 | $34.21 | 7.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 20 | $300.00 | $15.34 | 5.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 16 | $160.00 | $5.88 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 299 | $46,345 | $29,813 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 321 | $33,705 | $23,370 | 69.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 97 | 97 | $14,136 | $13,863 | 98.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 151 | 154 | $18,480 | $12,879 | 69.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 39 | 39 | $7,605 | $7,107 | 93.4% |
About Dr. Manan Pandya, DO
Dr. Manan Pandya, DO is a Internal Medicine healthcare provider based in Monroe, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1255659835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manan Pandya, DO has received a total of $15,227 in payments from pharmaceutical and medical device companies, with $1,183 received in 2024. These payments were reported across 1,027 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($15,187).
As a Medicare-enrolled provider, Pandya has provided services to 3,902 Medicare beneficiaries, totaling 4,613 services with total Medicare billing of $333,393. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Monroe, NJ
- Active Since 05/06/2010
- Last Updated 07/21/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255659835
Products in Payments
- FARXIGA (Drug) $1,303
- XIFAXAN (Drug) $949.34
- Kerendia (Drug) $824.54
- JARDIANCE (Drug) $758.20
- VRAYLAR (Drug) $604.12
- Ozempic (Drug) $571.88
- Saxenda (Drug) $530.46
- INJECTAFER (Drug) $393.34
- Xhance (Drug) $389.84
- TRULICITY (Drug) $363.92
- CHANTIX (Drug) $357.05
- Vascepa (Drug) $313.05
- ELIQUIS (Drug) $271.83
- Livalo (Drug) $259.65
- FASENRA (Biological) $255.17
- UBRELVY (Drug) $229.88
- TRELEGY ELLIPTA (Drug) $194.58
- TOUJEO (Drug) $174.31
- Victoza (Drug) $171.68
- MOUNJARO (Drug) $168.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Monroe
Nauman Khalid, Md, MD
Internal Medicine — Payments: $29,532
Gurmeet Singh, Do, DO
Internal Medicine — Payments: $12,910
Dr. Gaurav Chand, D.o, D.O
Internal Medicine — Payments: $10,898
Bryan Kirkland, Md, MD
Internal Medicine — Payments: $9,716
Dr. Narendra Kutnikar, Md, MD
Internal Medicine — Payments: $8,960
Dr. Frederick Lee, M.d, M.D
Internal Medicine — Payments: $8,445